EcoDrugPlus

Ensembl ID : YPL131W
Description: -
124 Possible Orthologues:

Title

Ensembl ID : YPL140C
Description: -
340 Possible Orthologues:

Title

Ensembl ID : YPL143W
Description: -
94 Possible Orthologues:

Title

Ensembl ID : YPL176C
Description: -
198 Possible Orthologues:

Title

Ensembl ID : YPL198W
Description: -
54 Possible Orthologues:

Title

Ensembl ID : YPL203W
Description: -
229 Possible Orthologues:

Title

Ensembl ID : YPL240C
Description: -
186 Possible Orthologues:

Title

Ensembl ID : YPL256C
Description: -
660 Possible Orthologues:

Title

Ensembl ID : YPL270W
Description: -
1259 Possible Orthologues:

Title

Ensembl ID : YPR068C
Description: -
93 Possible Orthologues:

Title

Ensembl ID : YPR108W
Description: -
74 Possible Orthologues:

Title

Ensembl ID : YPR119W
Description: -
661 Possible Orthologues:

Title

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).